Compare FTRE & PLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTRE | PLGO |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2023 | 2015 |
| Metric | FTRE | PLGO |
|---|---|---|
| Price | $18.59 | $27.48 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 9 |
| Target Price | $23.63 | ★ $27.39 |
| AVG Volume (30 Days) | ★ 1.7M | 403.4K |
| Earning Date | 10-29-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 3.22% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,723,400,000.00 | N/A |
| Revenue This Year | N/A | $11.98 |
| Revenue Next Year | $3.21 | $2.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.00 | N/A |
| 52 Week Low | $8.55 | $20.85 |
| 52 Week High | $26.16 | $29.70 |
| Indicator | FTRE | PLGO |
|---|---|---|
| Relative Strength Index (RSI) | 37.28 | 55.46 |
| Support Level | $16.34 | $23.95 |
| Resistance Level | $18.84 | $29.70 |
| Average True Range (ATR) | 1.34 | 0.86 |
| MACD | -0.31 | -0.13 |
| Stochastic Oscillator | 2.64 | 39.59 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Pelagos Insurance Capital Ltd operates in the specialty insurance and reinsurance sector. Its activities include capital allocation, risk selection, and the deployment of capital through underwriting partnerships across insurance and reinsurance markets. The company manages a diversified portfolio and works with underwriting partners to provide insurance and reinsurance solutions to clients and brokers.